AMICUS THERAPEUTICS, INC. — Director's Dealing 2016

Jun 17, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2016-06-15

Reporting Person: Quimi Daphne (SVP, Finance)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-06-15	Common Stock	A	8500	$0.00	Acquired	29877	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-15	Stock Options (right to buy)	$6.10	A	35000	Acquired	2026-06-15	Common Stock (35000)	Direct

Footnotes

F1: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on June 15, 2017. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on July 1, 2017, with the final installment vesting on June 1, 2020.